Delineation of the interactions between the chemotherapeutic agent eribulin mesylate (E7389) and human CYP3A4

By Zhang Z.-Y.   King B.   Pelletier R.   Wong Y.  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 4, 2008-09 ,pp. : 707-716

Springer Publishing Company

Access to resources Recommend Favorite

Inhibition of the enzyme activity of cytochrome P450 1A1, 1A2 and 3A4 by fucoxanthin, a marine carotenoid

By    

Oncology Letters, Vol. 6, Iss. 3, 2013-01 ,pp. : 860-864

Spandidos Publications

Access to resources Recommend Favorite

Effects of cotreatment with sulforaphane and autophagy modulators on uridine 5'-diphosphoglucuronosyltransferase 1A isoforms and cytochrome P450 3A4 expression in Caco2 human colon cancer cells

By  

Oncology Letters, Vol. 8, Iss. 6, 2014-01 ,pp. : 2407-2416

Spandidos Publications

Access to resources Recommend Favorite

Differences in the induction of cytochrome P450 3A4 by taxane anticancer drugs, docetaxel and paclitaxel, assessed employing primary human hepatocytes

By Nallani Srikanth   Goodwin Bryan   Buckley Arthur   Buckley Donna   Desai Pankaj  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 3, 2004-09 ,pp. : 219-229

Springer Publishing Company

Access to resources Recommend Favorite

The effect of P-glycoprotein and cytochrome P450 3a on the oral bioavailability of vinorelbine in mice

By Press Rogier   Buckle Tessa   Beijnen Jos   van Tellingen Olaf  

Cancer Chemotherapy and Pharmacology, Vol. 57, Iss. 6, 2006-06 ,pp. : 819-825

Springer Publishing Company

Access to resources Recommend Favorite